TY  - JOUR
AU  - Rios Peces, Sandra
AU  - Diaz Navarro, Caridad
AU  - Marquez Lopez, Cristina
AU  - Caba, Octavio
AU  - Jimenez-Luna, Cristina
AU  - Melguizo, Consolacion
AU  - Prados, Jose Carlos
AU  - Genilloud, Olga
AU  - Vicente Perez, Francisca
AU  - Perez Del Palacio, Jose
PY  - 2016
DO  - 10.1177/1087057116671490
UR  - http://hdl.handle.net/10668/10470
T2  - SLAS discovery : advancing life sciences R & D
AB  - Pancreatic ductal adenocarcinoma is one of the most lethal tumors since it is usually detected at an advanced stage in which surgery and/or current chemotherapy have limited efficacy. The lack of sensitive and specific markers for diagnosis leads to a...
LA  - en
PB  - Elsevier Inc.
KW  - biomarker
KW  - diagnosis
KW  - hydrophilic interaction liquid chromatography (HILIC)
KW  - liquid chromatography–high-resolution mass spectrometry (LC-HRMS)
KW  - pancreatic ductal adenocarcinoma (PDAC)
KW  - reverse-phase liquid chromatography (RPLC)
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Biomarkers, Tumor
KW  - Carcinoma, Pancreatic Ductal
KW  - Case-Control Studies
KW  - Chromatography, Liquid
KW  - Early Diagnosis
KW  - Female
KW  - Humans
KW  - Male
KW  - Mass Spectrometry
KW  - Metabolome
KW  - Metabolomics
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Pancreatic Neoplasms
KW  - Phospholipids
KW  - Principal Component Analysis
TI  - Untargeted LC-HRMS-Based Metabolomics for Searching New Biomarkers of Pancreatic Ductal Adenocarcinoma: A Pilot Study.
TY  - research article
VL  - 22
ER  -